CytoSorbents Corporation (CTSO)

[raptorjockey]

Thanks, Bertha for the link to cost factoring regarding AKI. It appears there are two basic sets of patients, those who's treatment does not require dialysis and those more acute that do. The cost between the two groups is substantial. An obvious goal of Doctors and labs would be to identify the patients that are most likely to become acute, in need of dialysis, and treat that group with our Cytosorbents filter, early. I don't know of any research aimed specifically at this complication, however I'm sure the lab results would have pretty good indicators pointing to those that would best benefit from our treatment, and at the same time, saving a ton of money by keeping a lot of patients out of the CC wards and rehab.